MARKET

CRRTF

CRRTF

Crescita Therape
OTCPK
0.350
NaN%
Closed 09:30 12/04 EST
OPEN
--
PREV CLOSE
0.350
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.390
52 WEEK LOW
0.340
MARKET CAP
6.51M
P/E (TTM)
20.00
1D
5D
1M
3M
1Y
5Y
1D
Crescita Therapeutics GAAP EPS of $0.04, revenue of $5.39M
Seeking Alpha · 11/05 18:36
Crescita Reports Third Quarter 2025 Results
Barchart · 11/05 06:30
Weekly Report: what happened at CRRTF last week (0908-0912)?
Weekly Report · 09/15 11:00
Weekly Report: what happened at CRRTF last week (0901-0905)?
Weekly Report · 09/08 11:02
Weekly Report: what happened at CRRTF last week (0825-0829)?
Weekly Report · 09/01 10:58
Weekly Report: what happened at CRRTF last week (0818-0822)?
Weekly Report · 08/25 11:07
Weekly Report: what happened at CRRTF last week (0811-0815)?
Weekly Report · 08/18 11:00
Weekly Report: what happened at CRRTF last week (0804-0808)?
Weekly Report · 08/11 11:06
More
About CRRTF
Crescita Therapeutics Inc. is a commercial dermatology company with in-house research and development (R&D) and manufacturing capabilities. It offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. It operates in three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The Commercial Skincare segment manufactures and sells branded non-prescription skincare products for the Canadian and international markets. It also commercializes Pliaglis, NCTF Boost 135 HA, ART FILLER, and Obagi Medical in Canada. The Licensing and Royalties segment is engaged in licensing the intellectual property related to Pliaglis or its transdermal delivery technologies. The Manufacturing and Services segment is engaged in the sale of topical products manufactured to client specifications under the Company’s contract development and manufacturing organization infrastructure, and product development services.

Webull offers Crescita Therapeutics Inc stock information, including OTCPK: CRRTF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRRTF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRRTF stock methods without spending real money on the virtual paper trading platform.